FdaApplication
ANDA 204723
Identifiers
- fda_app_no: ANDA204723
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2017-12-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLOPATADINE HYDROCHLORIDE | OLOPATADINE HYDROCHLORIDE | EQ 0.2% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product